Below are the most recent publications written about "Parathyroid Hormone" by people in Profiles.
-
Wang L, Cook NR, Manson JE, Gaziano JM, Buring JE, Sesso HD. Associations of Vitamin D-Related Biomarkers With Hypertension and the Renin-Angiotensin System in Men and Women. Am J Hypertens. 2024 11 15; 37(12):953-961.
-
Komaba H, Zhao J, Karaboyas A, Yamamoto S, Dasgupta I, Hassan M, Zuo L, Christensson A, Combe C, Robinson BM, Fukagawa M. Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPS. J Bone Miner Res. 2023 11; 38(11):1577-1585.
-
Fendrich V, Zahn A. [Localization diagnostics and operative strategy for the first intervention in sporadic primary hyperparathyroidism]. Chirurgie (Heidelb). 2023 Jul; 94(7):573-579.
-
Lindner K, Kussmann J, Fendrich V, Iwen KA, Zahn A. Adenoma weight: the only predictive factor for multiple gland disease in primary hyperparathyroidism. Minerva Endocrinol (Torino). 2025 Mar; 50(1):15-23.
-
Tobias DK, Luttmann-Gibson H, Mora S, Danik J, Bubes V, Copeland T, LeBoff MS, Cook NR, Lee IM, Buring JE, Manson JE. Association of Body Weight With Response to Vitamin D Supplementation and Metabolism. JAMA Netw Open. 2023 01 03; 6(1):e2250681.
-
Xie S, Kuriakose J, Beninato T, Carayannopoulos M, Trooskin SZ, Libutti SK, Laird AM. Association of Implementation of Operating Room-Based Parathyroid Hormone Testing with Operative Time and Cost. J Am Coll Surg. 2022 12 01; 235(6):906-912.
-
Limonte CP, Zelnick LR, Hoofnagle AN, Thadhani R, Melamed ML, Mora S, Cook NR, Luttmann-Gibson H, Sesso HD, Lee IM, Buring JE, Manson JE, de Boer IH. Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL. Kidney360. 2022 12 29; 3(12):2095-2105.
-
Gaur A, Lipponen J, Yang Y, Armen RS, Wang B. Mutation of Methionine to Asparagine but Not Leucine in Parathyroid Hormone Mimics the Loss of Biological Function upon Oxidation. Biochemistry. 2022 06 07; 61(11):981-991.
-
Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L, Hannan FM, Cetani F, Sikj?r T, Formenti AM, Bj?rnsdottir S, Schalin-Jantti C, Belaya Z, Gibb FW, Lapauw B, Amrein K, Wicke C, Grasemann C, Krebs M, Ryh?nen EM, Makay O, Minisola S, Gaujoux S, Bertocchio JP, Hassan-Smith ZK, Linglart A, Winter EM, Kollmann M, Zmierczak HG, Tsourdi E, Pilz S, Siggelkow H, Gittoes NJ, Marcocci C, Kamenicky P. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. Eur J Endocrinol. 2022 02 01; 186(2):R33-R63.
-
Sawamoto K, ?lvarez JV, Herre?o AM, Otero-Espinar FJ, Couce ML, Alm?ciga-D?az CJ, Tomatsu S. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders. Curr Osteoporos Rep. 2020 10; 18(5):515-525.